The embryonic mesoderm comprises heterogeneous cell subpopulations with distinct lineage biases.It is unclear whether a bias for the human hematopoietic lineage emerges at this early developmental stage.In this study,...The embryonic mesoderm comprises heterogeneous cell subpopulations with distinct lineage biases.It is unclear whether a bias for the human hematopoietic lineage emerges at this early developmental stage.In this study,we integrated single-cell transcriptomic analyses of human mesoderm cells from embryonic stem cells and embryos,enabling us to identify and define the molecular features of human hematopoietic mesoderm(HM)cells biased towards hematopoietic lineages.We discovered that BMP4 plays an essential role in HM specification and can serve as a marker for HM cells.Mechanistically,BMP4 acts as a downstream target of HDAC1,which modulates the expression of BMP4 by deacetylating its enhancer.Inhibition of HDAC significantly enhances HM specification and promotes subsequent hematopoietic cell differentiation.In conclusion,our study identifies human HM cells and describes new mechanisms for human hematopoietic development.展开更多
Runt-related transcription factor 1(RUNX1)is required for definitive hematopoiesis;however,the functions of most human RUNX1 isoforms are unclear.In particular,the effects of RUNX1-205(a novel splice variant that lack...Runt-related transcription factor 1(RUNX1)is required for definitive hematopoiesis;however,the functions of most human RUNX1 isoforms are unclear.In particular,the effects of RUNX1-205(a novel splice variant that lacks exon 6 in comparison with RUNX1b)on human hematopoiesis are not clear.In this study,a human embryonic stem cell(hESC)line with inducible RUNX1-205 overexpression was established.Analyses of these cells revealed that induction of RUNX1-205 overexpression at early stage did not influence the induction of mesoderm but blocked the emergence of CD34+cells,and the production of hematopoietic stem/progenitor cells was significantly reduced.In addition,the expression of hematopoiesis-related factors was downregulated.However,these effects were abolished when RUNX1-205 overexpression was induced after Day 6 in co-cultures of hESCs and AGM-S3 cells,indicating that the inhibitory effect occurred prior to generation of hemogenic endothelial cells,while the promotive effect could be observed during the late stage of hematopoiesis.This is very similar to that of RUNX1b.Interestingly,the mRNA expression profile of RUNX1-205 during hematopoiesis was distinct from that of RUNX1b,and the protein stability of RUNX1-205 was much higher than that of RUNX1b.Thus,the function of RUNX1-205 in normal and diseased models should be further explored.展开更多
The CCCTC-binding factor(CTCF)protein and its modified forms regulate gene expression and genome organization.However,information on CTCF acetylation and its biological function is still lacking.Here,we show that CTCF...The CCCTC-binding factor(CTCF)protein and its modified forms regulate gene expression and genome organization.However,information on CTCF acetylation and its biological function is still lacking.Here,we show that CTCF can be acetylated at lysine 20(CTCF-K20)by CREB-binding protein(CBP)and deacetylated by histone deacetylase 6(HDAC6).CTCF-K20 is required for the CTCF interaction with CBP.A CTCF point mutation at lysine 20 had no effect on self-renewal but blocked the mesoderm differentiation of mouse embryonic stem cells(mESCs).The CTCF-K20 mutation reduced CTCF binding to the promoters and enhancers of genes associated with early cardiac mesoderm differentia-tion,resulting in diminished chromatin accessibility and decreased enhancer-promoter interactions,impairing gene expression.In summary,this study reveals the important roles of CTCF-K20 in regulating CTCF genomic functions and mESC differentiation into mesoderm.展开更多
背景与目的:子宫恶性中胚叶混合瘤(malignant mixed mesodermal tumor,MMMT)是罕见的妇科恶性肿瘤,预后极差,是临床诊治的难点。本研究旨在探讨本病的临床、病理特征及孕激素受体亚型(progesterone receptor subtype A and B,PRA and P...背景与目的:子宫恶性中胚叶混合瘤(malignant mixed mesodermal tumor,MMMT)是罕见的妇科恶性肿瘤,预后极差,是临床诊治的难点。本研究旨在探讨本病的临床、病理特征及孕激素受体亚型(progesterone receptor subtype A and B,PRA and PRB)蛋白在子宫MMMT的表达及其意义。方法:回顾性分析17例患者的临床资料,并对其病理切片行光镜观察并应用免疫组化法测定PRA、PRB的表达情况,随访其中的11例患者。结果:①子宫MMMT表现缺乏特异性,主要表现为阴道出血。②病理上肿瘤成分复杂,形态多样,有上皮和间叶两种成分组成,相互间有穿插和移行变化。③同源性PRA阳性占55.6%,PRB阳性占33.3%;异源性PRA阳性占37.5%,PRB阳性占37.5%,两种亚型间差异无显著性(P>0.05)。PRA在Ⅰ期和Ⅱ期患者的表达率分别为66.7%和40%;PRB患者分别为55.6%和20%。④Ⅰ期患者平均存活43.8个月(32～59个月),Ⅱ期平均存活34.25个月(19～41个月);Ⅲ期1例,存活5个月。结论:子宫MMMT的诊断主要依赖组织形态学,疾病进展可能与PRA、PRB的丢失有关,PRA、PRB的表达可能与病理类型无关。预后可能与临床分期及PRA、PRB的表达有关。展开更多
基金supported by the CAMS Innovation Fund for Medical Sciences(2021-I2M-1-073,2021-I2M-1-040,2022-I2M-JB-015)the National Key Research and Development Program of China(2021YFA1100703,2021YFA1103000)+2 种基金Haihe Laboratory of Cell Ecosystem Innovation Fund(22HHXBSS00031)the National Natural Science Foundation of China(82125003,32271161,82200141)Tianjin Municipal Science and Technology Commission Grant(20JCYBJC00240,22ZXSYSY00010,22JCQNJC01270)。
文摘The embryonic mesoderm comprises heterogeneous cell subpopulations with distinct lineage biases.It is unclear whether a bias for the human hematopoietic lineage emerges at this early developmental stage.In this study,we integrated single-cell transcriptomic analyses of human mesoderm cells from embryonic stem cells and embryos,enabling us to identify and define the molecular features of human hematopoietic mesoderm(HM)cells biased towards hematopoietic lineages.We discovered that BMP4 plays an essential role in HM specification and can serve as a marker for HM cells.Mechanistically,BMP4 acts as a downstream target of HDAC1,which modulates the expression of BMP4 by deacetylating its enhancer.Inhibition of HDAC significantly enhances HM specification and promotes subsequent hematopoietic cell differentiation.In conclusion,our study identifies human HM cells and describes new mechanisms for human hematopoietic development.
基金supported by grants from the CAMS Initiatives for Innovative Medicine(2016-I2M-1-018 to F.M.and 2017-I2M-3-021 to J.L.)the Sichuan Provincial Health and Family Planning Commissi on research project(17PJ489 to B.C.)Chengdu Science and Technology Project-Technology Innovation R&D(2018-YF05-01341-SN to B.C.).
文摘Runt-related transcription factor 1(RUNX1)is required for definitive hematopoiesis;however,the functions of most human RUNX1 isoforms are unclear.In particular,the effects of RUNX1-205(a novel splice variant that lacks exon 6 in comparison with RUNX1b)on human hematopoiesis are not clear.In this study,a human embryonic stem cell(hESC)line with inducible RUNX1-205 overexpression was established.Analyses of these cells revealed that induction of RUNX1-205 overexpression at early stage did not influence the induction of mesoderm but blocked the emergence of CD34+cells,and the production of hematopoietic stem/progenitor cells was significantly reduced.In addition,the expression of hematopoiesis-related factors was downregulated.However,these effects were abolished when RUNX1-205 overexpression was induced after Day 6 in co-cultures of hESCs and AGM-S3 cells,indicating that the inhibitory effect occurred prior to generation of hemogenic endothelial cells,while the promotive effect could be observed during the late stage of hematopoiesis.This is very similar to that of RUNX1b.Interestingly,the mRNA expression profile of RUNX1-205 during hematopoiesis was distinct from that of RUNX1b,and the protein stability of RUNX1-205 was much higher than that of RUNX1b.Thus,the function of RUNX1-205 in normal and diseased models should be further explored.
基金This work was supported in part by grants from the National Key R&D Program of China(2021YFA1100300)Strategic Priority Research Program of the Chinese Academy of Sciences(XDA16010502)+2 种基金National Natural Science Foundation of China(31925009,U21A20195,32000424,32100462,32100463,and 81902885)Science and Technology Planning Project of Guangdong Province,China(2019B020234004,2019A050510004 and 2020B1212060052)Macao Science and Technology Development Fund(FDCT0107/2019/A2).
文摘The CCCTC-binding factor(CTCF)protein and its modified forms regulate gene expression and genome organization.However,information on CTCF acetylation and its biological function is still lacking.Here,we show that CTCF can be acetylated at lysine 20(CTCF-K20)by CREB-binding protein(CBP)and deacetylated by histone deacetylase 6(HDAC6).CTCF-K20 is required for the CTCF interaction with CBP.A CTCF point mutation at lysine 20 had no effect on self-renewal but blocked the mesoderm differentiation of mouse embryonic stem cells(mESCs).The CTCF-K20 mutation reduced CTCF binding to the promoters and enhancers of genes associated with early cardiac mesoderm differentia-tion,resulting in diminished chromatin accessibility and decreased enhancer-promoter interactions,impairing gene expression.In summary,this study reveals the important roles of CTCF-K20 in regulating CTCF genomic functions and mESC differentiation into mesoderm.
基金Acknowledgements We thank Drs Alex Schier and Susan Mango （Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA） for discussion and suggestions, Dr David Kimelman （Department of Biochemistry, University of Washington, Seattle, WA, USA） for myc-eomesa construct, and members of the Meng lab for discussion and technical assistance.
This work was financially supported by grants from the Major Science Research Programs of China （2011CB943800） and the National Natural Science Foundation of China （31221064）.
基金This work was supported by the National Program on Key Basic Research Project of China （973 Program 2015CB964902）, the National Natural Science Foundation of China （NSFC H81170466 and H81370597）, and the CAMS Initiatives for Innovative Medicine （2016-12M-1-018） awarded to F.M.
文摘背景与目的:子宫恶性中胚叶混合瘤(malignant mixed mesodermal tumor,MMMT)是罕见的妇科恶性肿瘤,预后极差,是临床诊治的难点。本研究旨在探讨本病的临床、病理特征及孕激素受体亚型(progesterone receptor subtype A and B,PRA and PRB)蛋白在子宫MMMT的表达及其意义。方法:回顾性分析17例患者的临床资料,并对其病理切片行光镜观察并应用免疫组化法测定PRA、PRB的表达情况,随访其中的11例患者。结果:①子宫MMMT表现缺乏特异性,主要表现为阴道出血。②病理上肿瘤成分复杂,形态多样,有上皮和间叶两种成分组成,相互间有穿插和移行变化。③同源性PRA阳性占55.6%,PRB阳性占33.3%;异源性PRA阳性占37.5%,PRB阳性占37.5%,两种亚型间差异无显著性(P>0.05)。PRA在Ⅰ期和Ⅱ期患者的表达率分别为66.7%和40%;PRB患者分别为55.6%和20%。④Ⅰ期患者平均存活43.8个月(32～59个月),Ⅱ期平均存活34.25个月(19～41个月);Ⅲ期1例,存活5个月。结论:子宫MMMT的诊断主要依赖组织形态学,疾病进展可能与PRA、PRB的丢失有关,PRA、PRB的表达可能与病理类型无关。预后可能与临床分期及PRA、PRB的表达有关。
